id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0883-0002,FDA,FDA-2011-N-0883,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products",Notice,General Notice,2012-03-20T04:00:00Z,2012,3,2012-03-20T04:00:00Z,2012-04-20T03:59:59Z,2012-03-24T19:32:54Z,2012-06693,0,0,0900006480fdb768
FDA-2011-N-0883-0001,FDA,FDA-2011-N-0883,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products",Notice,General Notice,2011-12-19T05:00:00Z,2011,12,2011-12-19T05:00:00Z,2012-02-18T04:59:59Z,2011-12-19T14:24:12Z,2011-32397,0,0,0900006480f858fa